Efficacy and influencing factors of percutaneous sclerotherapy for venous malformations of the knee in children. [PDF]
Front PediatrLiu Z, Zhang X, Wang L, Li J, Song D.
europepmc +1 more source
Comment on "Is Injectable Sclerotherapy with Polidocanol Foam Effective for Treating Hemorrhoids in Patients with Severe Anemia?" [PDF]
J Anus Rectum ColonSegalini E, Torre JD, Longo A.
europepmc +1 more source
Direct transvaginal ultrasound-guided sclerotherapy for pelvic venous disease. [PDF]
J Vasc Surg Venous Lymphat DisordHipola JM +4 more
europepmc +1 more source
A randomized controlled trial of 3% polidocanol foam with saline prewashing compared with standard foam sclerotherapy for the treatment of varicose veins. [PDF]
J Vasc Surg Venous Lymphat DisordRocha LAF +7 more
europepmc +1 more source
Letter regarding "polidocanol 3% foam for varicose veins". [PDF]
J Vasc Surg Venous Lymphat DisordSati DM +3 more
europepmc +1 more source
Cap-assisted endoscopic sclerotherapy for bleeding-predominant grade III hemorrhoids: efficacy and risk factor analysis focusing on two dimensions of bleeding score. [PDF]
Tech ColoproctolWu GJ, Xun Y, Yu S, Tang X, Jin Y.
europepmc +1 more source
Case Cluster of Necrotizing Fasciitis and Cellulitis Associated with Vein Sclerotherapy
Emerging Infectious Diseases, 2008 Hiu-Tat Chan +5 more
doaj +1 more source
Clinical outcome of pingyangmycin-polidocanol foam versus pingyangmycin alone in pediatric cystic lymphatic malformation with intracapsular hemorrhage: A retrospective cohort study. [PDF]
Medicine (Baltimore)Fang S, Cao J, Shen G.
europepmc +1 more source
Correspondence for the article titled: "Effectiveness and safety of 3% polidocanol foam sclerotherapy in hemorrhoidal disease: a multicenter, prospective study". [PDF]
Int J Colorectal DisMalik MMUD, Jayaswal RP.
europepmc +1 more source